{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:51:50Z","timestamp":1761580310929},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,9,1]],"date-time":"1991-09-01T00:00:00Z","timestamp":683683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[1991,9]]},"DOI":"10.1007\/bf01612758","type":"journal-article","created":{"date-parts":[[2005,4,30]],"date-time":"2005-04-30T02:50:37Z","timestamp":1114829437000},"page":"403-408","source":"Crossref","is-referenced-by-count":24,"title":["Investigation into the immunological effects of miltefosine, a new anticancer agent under development"],"prefix":"10.1007","volume":"117","author":[{"given":"P.","family":"Hilgard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kampherm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Reissmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/BF02535540","volume":"22","author":"R Andreesen","year":"1987","unstructured":"Andreesen R, Giese V (1987) Differential effects of ether lipids on the activity and secretion of interleukin-1 and interleukin-2. Lipids 22:836\u2013841","journal-title":"Lipids"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jnci\/72.1.53","volume":"72","author":"R Andreesen","year":"1984","unstructured":"Andreesen R, Osterholz J, Luckenbach GA, Costabel U, Schulz A, Speth V, Munder PG, L\u00f6hr GW (1984) Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine. JNCI 72:53\u201359","journal-title":"JNCI"},{"key":"CR3","first-page":"345","volume":"1","author":"WE Berdel","year":"1981","unstructured":"Berdel WE, Bausert WRE, Fink V, Rastetter J, Munder PG (1981) Antitumour action of alkyllysophospholipids (review). Anticancer Res 1:345\u2013352","journal-title":"Anticancer Res"},{"key":"CR4","first-page":"1149","volume":"24","author":"N Brock","year":"1974","unstructured":"Brock N, Potel J (1974) Pharmakologische Untersuchungen mit Alkylsulfonyloxyalkyl-bzw. Chlor\u00c4thyl-substituierten Oxazaphosphorin-2-oxiden. 2. Mitteilung: Pharmakologische Charakterisierung von 2-Alkylsulfonyl-oxy-alkylamino-oxazaphosphorin-2-oxiden unter Einbeziehung immunologischer Reaktionen. Arneim-Forsch\/Drug Res 24:1149\u20131160","journal-title":"Arneim-Forsch\/Drug Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1515\/znb-1964-1207","volume":"19 B","author":"K Burdzy","year":"1964","unstructured":"Burdzy K, Munder PG, Fischer H, Westphal O (1964) Steigerung der Phagozytose von Peritonealmakrophagen durch Lysolecithin. Z Naturforsch 19 B:1118\u20131120","journal-title":"Z Naturforsch"},{"key":"CR6","first-page":"161","volume-title":"Progress in cancer research and therapy, vol 19","author":"IY Djev","year":"1981","unstructured":"Djev IY, Timonen T, Herbermann RB (1981) Augmentation of natural killer cell activity and induction of interferon by tumor cells and other biological response modifiers. In: Chirigos MA, Mitchell M, Mastrangelo MJ, Krim M (eds) Progress in cancer research and therapy, vol 19. Raven Press, New York, pp 161\u2013166"},{"key":"CR7","first-page":"1","volume":"34","author":"H Eibl","year":"1987","unstructured":"Eibl H, Unger C (1987) Phospholipide als Antitumormittel: M\u00f6glichkeiten einer selektiven Therapie. Aktuel Onkol 34:1\u201318","journal-title":"Aktuel Onkol"},{"key":"CR8","first-page":"889","volume":"116","author":"H Grunicke","year":"1990","unstructured":"Grunicke H, Hofmann J, Oberhuber H, \u00fcberall F, Zaknun J, Voegeli R, Hilgard P (1990) Hexadecylphosphocholine inhibits protein kinase-C and depresses the inositol phosphate response in NIH 3T3 fibroblasts (abstract). J Cancer Res Clin Oncol 116:889","journal-title":"J Cancer Res Clin Oncol"},{"key":"CR9","first-page":"135","volume-title":"The nude mouse in experimental and clinical research","author":"RB Herberman","year":"1978","unstructured":"Herberman RB (1978) Natural cell-mediated cytotoxicity in nude mice. In: Fogh J, Giovanella BC (eds) The nude mouse in experimental and clinical research. Academic Press, London, pp 135\u2013166"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0305-7372(85)90036-2","volume":"12","author":"P Hilgard","year":"1985","unstructured":"Hilgard P, Pohl J, Stekar J, Voegeli R (1985) Oxazaphosphorines as biological response modifiers \u2014 experimental and clinical perspectives. Cancer Treat Rev 12:155\u2013162","journal-title":"Cancer Treat Rev"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0277-5379(88)90336-7","volume":"24","author":"P Hilgard","year":"1988","unstructured":"Hilgard P, Stekar J, Voegeli R, Engel J, Schumacher W, Eibl H, Unger C, Berger MR (1988) Characterization of the antitumor activity of hexadecylphosphocholine (D-18506). Eur J Cancer Clin Oncol 24:1457\u20131461","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR12","first-page":"174","volume":"17","author":"PG M\u00fcnder","year":"1976","unstructured":"M\u00fcnder PG, Fischer H, Weltzien HV, Oettgen HF, Westphal O (1976) Lysolecithin analogs: a new class of immunopotentiators with antitumor activity. Proc Am Assoc Cancer Res 17:174","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR13","first-page":"1380","volume":"10","author":"B Pignol","year":"1990","unstructured":"Pignol B, Coulomb H, Chaumeron S, Maisonnet T, Vandamme B, Broquet C, Mencia-Huerta J-M, Braquet P (1990) Effect of synthetic alkyllsophosphatidylcholine (ALP) on IL-1, TNF and IL-2 productions (abstract). Anticancer Res 10:1380","journal-title":"Anticancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF00391352","volume":"115","author":"T Reissmann","year":"1989","unstructured":"Reissmann T, Hilgard P, Voegeli R, Zeller J (1989) Evidence of a role for NK cells in oxazaphosphorine mediated tumor regression. J Cancer Res Clin Oncol 115:525\u2013530","journal-title":"J Cancer Res Clin Oncol"},{"key":"CR15","first-page":"3","volume-title":"Thymusaplastic nude mice and rats in clinical oncology","author":"J Rygaard","year":"1981","unstructured":"Rygaard J (1981) Immunodeficiency in nude mice. In: Bastert GB, Fortmeyer HP, Schmidt-Matthiesen H (eds) Thymusaplastic nude mice and rats in clinical oncology. Fischer, Stuttgart, pp 3\u201313"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/BF02535547","volume":"22","author":"JE Talmadge","year":"1987","unstructured":"Talmadge JE, Schneider M, Lenz B, Phillips H, Long C (1987) Immunomodulatory and therapeutic properties of alkyl lysophospholipids in mice. Lipids 22:871\u2013877","journal-title":"Lipids"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-1759(85)90416-8","volume":"84","author":"K Zier","year":"1985","unstructured":"Zier K (1985) Generation of antigen specific cytotoxic T-lymphocytes directed against class II molecules expressed by activated T-cells. J Immunol Methods 84:73\u201384","journal-title":"J Immunol Methods"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01612758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01612758\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01612758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T14:14:49Z","timestamp":1557238489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01612758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,9]]}},"alternative-id":["BF01612758"],"URL":"https:\/\/doi.org\/10.1007\/bf01612758","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,9]]}}}